|
Volumn 23, Issue 6 SUPPL. 16, 1996, Pages 18-25
|
The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
PACLITAXEL;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
LUNG SMALL CELL CANCER;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SMALL CELL;
CISPLATIN;
ETOPOSIDE;
HUMANS;
LUNG NEOPLASMS;
NEUTROPENIA;
PACLITAXEL;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
|
EID: 0030461631
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (11)
|
References (34)
|